Filing Details
- Accession Number:
- 0001179110-15-003094
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-02-20 17:51:56
- Reporting Period:
- 2015-02-17
- Filing Date:
- 2015-02-20
- Accepted Time:
- 2015-02-20 17:51:56
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1070081 | Ptc Therapeutics Inc. | PTCT | Pharmaceutical Preparations (2834) | 043416587 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1578850 | Gregory Neil Almstead | C/O Ptc Therapeutics, Inc. 100 Corporate Court South Plainfield NJ 07080 | Evp, Research And Cmc | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-02-17 | 3,592 | $10.85 | 33,473 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2015-02-17 | 312 | $10.85 | 33,785 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-02-17 | 1,504 | $53.37 | 32,281 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-02-17 | 2,400 | $54.56 | 29,881 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right To Buy) | Acquisiton | 2015-02-17 | 3,592 | $0.00 | 3,592 | $10.85 |
Common Stock | Stock Option (Right To Buy) | Acquisiton | 2015-02-17 | 312 | $0.00 | 312 | $10.85 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
70,312 | 2023-05-15 | No | 4 | M | Direct | |
9,688 | 2023-05-15 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 1,374 | Indirect | By spouse |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan.
- This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $53.10 to $54.05 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $54.18 to $54.70 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- This option was granted on May 15, 2013 and vests over four years, with 25% of the shares underlying the option vested on May 15, 2014 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter beginning on June 30, 2014.
- This option was granted on May 15, 2013 and vests over four years, with 25% of the shares underlying the option vested on December 31, 2013 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter beginning on January 31, 2014.